Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

NCT01677260 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dexa Medica Group